‘Big Data’, Device Reprocessing Among FDA's Device Science Goals

FDA’s device Center Science Council wants to leverage “big data” and evidence from real-world clinical experience, improve reprocessing of reusable medical devices and enhance use of health information technology and device cybersecurity, among other FY 2016 regulatory science goals.

FDA’s device center wants to better leverage "big data," evidence from clinical experience, and patient-reported outcome measures, among other goals, to assist in regulatory decision making, the division’s Center Science Council says in an Oct. 20 document

listing the center’s top 10 science priorities for fiscal-year 2016.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation